Zepp Health (ZEPP) Common Equity (2016 - 2024)
Zepp Health has reported Common Equity over the past 10 years, most recently at $252.7 million for Q4 2024.
- Quarterly results put Common Equity at $252.7 million for Q4 2024, down 27.34% from a year ago — trailing twelve months through Dec 2024 was $252.7 million (down 27.34% YoY), and the annual figure for FY2024 was $252.7 million, down 27.97%.
- Common Equity for Q4 2024 was $252.7 million at Zepp Health, down from $347.8 million in the prior quarter.
- Over the last five years, Common Equity for ZEPP hit a ceiling of $458.8 million in Q4 2021 and a floor of $252.7 million in Q4 2024.
- Median Common Equity over the past 5 years was $375.8 million (2022), compared with a mean of $369.4 million.
- Biggest five-year swings in Common Equity: increased 16.26% in 2020 and later decreased 27.34% in 2024.
- Zepp Health's Common Equity stood at $412.0 million in 2020, then rose by 11.37% to $458.8 million in 2021, then fell by 18.1% to $375.8 million in 2022, then fell by 7.43% to $347.8 million in 2023, then decreased by 27.34% to $252.7 million in 2024.
- The last three reported values for Common Equity were $252.7 million (Q4 2024), $347.8 million (Q4 2023), and $375.8 million (Q4 2022) per Business Quant data.